Navigation Links
FDA's control is inherently weak

The Food and Drug Administration has few details about the dramatic rise in overseas drug testing and reforms are needed to protect both foreign patients taking experimental medicines and Americans who buy products based on their results.

The number of pharmaceutical researchers working outside the United States who voluntarily report their experiments to the FDA increased 16-fold from 1990 to 1999, dwarfing the agency's ability to inspect the test sites. More worrisome, is that the FDA does not know how many such tests are not reported.// " It's a serious problem, it's growing, there needs to be something done about it right away," George Grob, a deputy HHS inspector general, said.

In recent weeks, the FDA has opened a criminal investigation into irregularities in a Nigerian drug trial sponsored by Pfizer Inc., and the families of 30 children who participated in the study have filed suit against Pfizer in New York. The FDA is unable to ensure that trial participants in those countries receive the same level of protection as those in the United States.

The FDA has little idea where research takes place overseas, what level of ethics review exists, how foreign researchers recruit participants or how many patients are taking experimental medicines.


'"/>




Page: 1

Related medicine news :

1. Uncontrolled blood pressure
2. Drugs control and industry departments to share a common e-platform
3. Self control makes stress response easy
4. Progression of Glaucoma could be controlled with early detection
5. New way to control hospital infection
6. Scientists locate key hormone involved in appetite control
7. Blood pressure control with ACE inhibitor or diuretic?
8. Diet and exercise can be a better option to control diabetes
9. Link found between depression and poor glycemic control
10. Lower risk of cardiovascular disease from tight glucose control
11. Expose on eating disorders!! Scientists trace “brain’s eating control center pathway”
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:4/29/2016)... ... 29, 2016 , ... Melanoma is the deadliest type of skin cancer. Although only about 1 ... skin cancer deaths. More than 10,000 people are expected to die of melanoma this year. ... is the one of the most commonly diagnosed cancers in young women. A recent breakthrough ...
(Date:4/29/2016)... ... April 29, 2016 , ... Reltok Nasal Products proudly announces that Boston ... and neck/ear, nose and throat specialty, has added the KOTLER NASAL AIRWAY™ to its ... is a newly patented safety device secured by nasal surgeons onto the floor ...
(Date:4/29/2016)... ... April 29, 2016 , ... ... Dairy Products, Inc. in an upcoming episode, airing third quarter 2016 via Discovery ... churning cream into butter, Grassland Dairy Products, located in Greenwood, Wisconsin applies product ...
(Date:4/29/2016)... ... April 29, 2016 , ... The infertility specialists at HRC Fertility/Orange County ... Dr. Daniel A. Potter -- are proud of the recent release of their 2014 ... April, SART published the latest verified data for 375 U.S. member clinics. ...
(Date:4/29/2016)... ... 29, 2016 , ... International Dehydrated Foods, Inc. (IDF™) will attend and sponsor ... the Doubletree by Hilton Hotel in Oak Brook, Illinois. The two-day event is the ... protein ingredients. , At the seminar, IDF™ will offer samples of its Savory ...
Breaking Medicine News(10 mins):
(Date:4/28/2016)... , Net Sales of $1.90 billion represent an increase ... period, and an increase of 1.2% on an adjusted pro ... first quarter were $0.52 reported, a decrease of 47.5% from ... 29.9% over the prior year period , The Company ... Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH) ...
(Date:4/28/2016)... April 28, 2016  ValGenesis, Inc., the ... Solutions (VLMS) today announced that a prominent ... sufferers of chronic kidney failure has selected ... their corporate validation process. The global medical ... solution to manage their validation processes electronically. ...
(Date:4/27/2016)... , Schweiz, April 27, 2016 /PRNewswire/ ... des Sachs CEO Forums in Zürich gab ... ihres führenden Wirkstoffkandidaten STR001 zur Erhaltung des ... eingesetzt wurde, bekannt. Für die umfassende Phase-II-Doppelblindstudie ... und Frankreich angeworben. STR001 wird während der ...
Breaking Medicine Technology: